Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.
Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
Some people with blood cancers, however, may not be as well protected.
The coronavirus vaccines are safe and should be effective even for people with advanced cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.